Variant report
Variant | nsv818926 |
---|---|
Chromosome Location | chr12:73991642-73992674 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12427195 | chr12:73991642-73991643 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs374311104 | chr12:73991676-73991677 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs573812660 | chr12:73991684-73991685 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs11608269 | chr12:73991711-73991712 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs543849694 | chr12:73991724-73991725 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146297071 | chr12:73991782-73991783 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs574447439 | chr12:73991872-73991873 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs192385902 | chr12:73991905-73991906 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs139639219 | chr12:73991939-73991940 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185575442 | chr12:73991965-73991966 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs546040287 | chr12:73991977-73991978 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs562736501 | chr12:73992007-73992008 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190398138 | chr12:73992020-73992021 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181643548 | chr12:73992048-73992049 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568488479 | chr12:73992074-73992075 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185141181 | chr12:73992085-73992086 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs144260192 | chr12:73992193-73992194 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs530949377 | chr12:73992254-73992255 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs370787349 | chr12:73992256-73992257 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs150987182 | chr12:73992340-73992341 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs7953612 | chr12:73992354-73992355 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs189127603 | chr12:73992450-73992451 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545297131 | chr12:73992486-73992487 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs11833832 | chr12:73992508-73992509 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs570234401 | chr12:73992540-73992541 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181126982 | chr12:73992541-73992542 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs554261332 | chr12:73992570-73992571 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2730548 | chr12:73992585-73992586 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540835721 | chr12:73992654-73992655 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs2730549 | chr12:73992674-73992675 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 16620391 | CNVD |
Disease | 21505450 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 17133270 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:73991200-73992000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr12:73991200-73994000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr12:73991400-73992000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
4 | chr12:73991600-73991800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr12:73991600-73993800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr12:73991800-73992800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
7 | chr12:73992000-73992800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr12:73992000-73993600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr12:73992000-73994000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr12:73992000-73994200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |